These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 12679485)

  • 1. Genome-wide copy number imbalances identified in familial and sporadic medullary thyroid carcinoma.
    Marsh DJ; Theodosopoulos G; Martin-Schulte K; Richardson AL; Philips J; Röher HD; Delbridge L; Robinson BG
    J Clin Endocrinol Metab; 2003 Apr; 88(4):1866-72. PubMed ID: 12679485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CGH alterations in medullary thyroid carcinomas in relation to the RET M918T mutation and clinical outcome.
    Frisk T; Zedenius J; Lundberg J; Wallin G; Kytölä S; Larsson C
    Int J Oncol; 2001 Jun; 18(6):1219-25. PubMed ID: 11351254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low frequency of germline mutations in the RET proto-oncogene in patients with apparently sporadic medullary thyroid carcinoma.
    Eng C; Mulligan LM; Smith DP; Healey CS; Frilling A; Raue F; Neumann HP; Ponder MA; Ponder BA
    Clin Endocrinol (Oxf); 1995 Jul; 43(1):123-7. PubMed ID: 7641404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RET proto-oncogene mutations in multiple endocrine neoplasia type 2 and medullary thyroid carcinoma.
    Marsh DJ; Mulligan LM; Eng C
    Horm Res; 1997; 47(4-6):168-78. PubMed ID: 9167949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneous mutation of the RET proto-oncogene in subpopulations of medullary thyroid carcinoma.
    Eng C; Mulligan LM; Healey CS; Houghton C; Frilling A; Raue F; Thomas GA; Ponder BA
    Cancer Res; 1996 May; 56(9):2167-70. PubMed ID: 8616867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinction between sporadic and hereditary medullary thyroid carcinoma (MTC) by mutation analysis of the RET proto-oncogene. "Study Group Multiple Endocrine Neoplasia Austria (SMENA)".
    Fink M; Weinhüsel A; Niederle B; Haas OA
    Int J Cancer; 1996 Aug; 69(4):312-6. PubMed ID: 8797874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Very early detection of RET proto-oncogene mutation is crucial for preventive thyroidectomy in multiple endocrine neoplasia type 2 children: presence of C-cell malignant disease in asymptomatic carriers.
    Sanso GE; Domene HM; Garcia R; Pusiol E; de M; Roque M; Ring A; Perinetti H; Elsner B; Iorcansky S; Barontini M
    Cancer; 2002 Jan; 94(2):323-30. PubMed ID: 11900218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of medullary thyroid carcinoma in transgenic mice expressing the RET protooncogene altered by a multiple endocrine neoplasia type 2A mutation.
    Michiels FM; Chappuis S; Caillou B; Pasini A; Talbot M; Monier R; Lenoir GM; Feunteun J; Billaud M
    Proc Natl Acad Sci U S A; 1997 Apr; 94(7):3330-5. PubMed ID: 9096393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Germline and somatic mutations of the RET proto-oncogene in apparently sporadic medullary thyroid carcinomas.
    Scurini C; Quadro L; Fattoruso O; Verga U; Libroia A; Lupoli G; Cascone E; Marzano L; Paracchi S; Busnardo B; Girelli ME; Bellastella A; Colantuoni V
    Mol Cell Endocrinol; 1998 Feb; 137(1):51-7. PubMed ID: 9607728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of RET proto-oncogene abnormalities in patients with MEN 2A, MEN 2B, familial or sporadic medullary thyroid carcinoma.
    Chiefari E; Russo D; Giuffrida D; Zampa GA; Meringolo D; Arturi F; Chiodini I; Bianchi D; Attard M; Trischitta V; Bruno R; Giannasio P; Pontecorvi A; Filetti S
    J Endocrinol Invest; 1998 Jun; 21(6):358-64. PubMed ID: 9699127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatic and MEN 2A de novo mutations identified in the RET proto-oncogene by screening of sporadic MTC:s.
    Zedenius J; Wallin G; Hamberger B; Nordenskjöld M; Weber G; Larsson C
    Hum Mol Genet; 1994 Aug; 3(8):1259-62. PubMed ID: 7987299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatic mutations of the ret protooncogene in sporadic medullary thyroid carcinoma are not restricted to exon 16 and are associated with tumor recurrence.
    Romei C; Elisei R; Pinchera A; Ceccherini I; Molinaro E; Mancusi F; Martino E; Romeo G; Pacini F
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1619-22. PubMed ID: 8636377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Germline mutations of the ret proto-oncogene in Chilean patients with hereditary and sporadic medullary thyroid carcinoma].
    Wohllk N; Becker P; Youlton R; Cote GJ; Gagel RF
    Rev Med Chil; 2001 Jul; 129(7):713-8. PubMed ID: 11552438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Somatic ret proto-oncogene mutations in sporadic C-cell carcinoma of the thyroid gland].
    Frilling A; Bockhorn M; Kalinin V; Liedke M; Kaun M; Broelsch CE
    Chirurg; 1997 Aug; 68(8):789-93. PubMed ID: 9377989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Proto-oncogene RET somatic mutations in medullary thyroid carcinoma].
    Wiench M; Kwaśniewski M; Gubała E; Wygoda Z; Pawlaczek A; Oczko M; Jarzab B
    Wiad Lek; 2001; 54 Suppl 1():415-21. PubMed ID: 12182058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Germline sequence variant S836S in the RET proto-oncogene is associated with low level predisposition to sporadic medullary thyroid carcinoma in the Spanish population.
    Ruiz A; Antiñolo G; Fernández RM; Eng C; Marcos I; Borrego S
    Clin Endocrinol (Oxf); 2001 Sep; 55(3):399-402. PubMed ID: 11589684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The oncogenic activity of RET point mutants for follicular thyroid cells may account for the occurrence of papillary thyroid carcinoma in patients affected by familial medullary thyroid carcinoma.
    Melillo RM; Cirafici AM; De Falco V; Bellantoni M; Chiappetta G; Fusco A; Carlomagno F; Picascia A; Tramontano D; Tallini G; Santoro M
    Am J Pathol; 2004 Aug; 165(2):511-21. PubMed ID: 15277225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular and biochemical screening for the diagnosis and management of medullary thyroid carcinoma in multiple endocrine neoplasia type 2A.
    Vieira AE; Mello MP; Elias LL; Lau IF; Maciel LM; Moreira AC; Castro M
    Horm Metab Res; 2002 Apr; 34(4):202-6. PubMed ID: 11987030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel germline RET proto-oncogene mutations associated with medullary thyroid carcinoma (MTC): mutation analysis in Japanese patients with MTC.
    Kitamura Y; Goodfellow PJ; Shimizu K; Nagahama M; Ito K; Kitagawa W; Akasu H; Takami H; Tanaka S; Wells SA
    Oncogene; 1997 Jun; 14(25):3103-6. PubMed ID: 9223675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rudolf-Virchow-Preis 1995. The role of RET proto-oncogene mutation analysis in the diagnosis of multiple endocrine neoplasia type 2 (MEN 2) gene carriers and in the discrimination of sporadic and familial medullary thyroid carcinomas and pheochromocytomas.
    Komminoth P
    Verh Dtsch Ges Pathol; 1995; 79():L-LV. PubMed ID: 8600671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.